CIK 0001739410
- Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851083789
- Phone
- +1 203-859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,608
- in 1 filing
Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-14 | Ryder Steven Chief Medical Officer | Grant or award · Option (Right to Buy) | +180,000 | 180,000 | ||
| 2024-02-15 | Ryder Steven Chief Medical Officer | Grant or award · Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-02-06 | Ryder Steven Chief Medical Officer | Grant or award · Option (Right to Buy) | +119,000 | 119,000 | ||
| 2022-02-07 | Ryder Steven Chief Medical Officer | Grant or award · Option (Right to Buy) | +62,000 | 62,000 |
Page 1 of 1 · 4 trades